HAP1 can inhibit the nuclear translocation of gene products of a number of neurodegenerative diseases such as Huntington’s disease, Machado-Joseph disease and SBMA (Metzger et al., 2008; Takeshita et al., 2006, 2011). This evidence concerns the gene HAP1 and juvenile Huntington disease.